Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2451 entries
Sorted by: Best Match Show Resources per page
Editorial to Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology.

Pharmacopsychiatry

Gründer G.
PMID: 28926859
Pharmacopsychiatry. 2018 Jan;51(1):5-6. doi: 10.1055/s-0043-118103. Epub 2017 Sep 19.

No abstract available.

Cite
Gründer G. Editorial to Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology. Pharmacopsychiatry. 2017;51(1):5-6doi: 10.1055/s-0043-118103.
Gründer, G. (2018). Editorial to Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology. Pharmacopsychiatry, 51(1), 5-6. https://doi.org/10.1055/s-0043-118103
Gründer, Gerhard. "Editorial to Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology." Pharmacopsychiatry vol. 51,1 (2018): 5-6. doi: https://doi.org/10.1055/s-0043-118103
Gründer G. Editorial to Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology. Pharmacopsychiatry. 2018 Jan;51(1):5-6. doi: 10.1055/s-0043-118103. Epub 2017 Sep 19. PMID: 28926859.
Copy Download .nbib Format: NLM
Erratum.

The international journal of neuropsychopharmacology

[No authors listed]
PMID: 28927198
Int J Neuropsychopharmacol. 2017 Jan 01;20(1):94. doi: 10.1093/ijnp/pyw104.

No abstract available.

Cite
Erratum. Int J Neuropsychopharmacol. 2017;20(1):94doi: 10.1093/ijnp/pyw104.
(2017). Erratum. The international journal of neuropsychopharmacology, 20(1), 94. https://doi.org/10.1093/ijnp/pyw104
"Erratum." The international journal of neuropsychopharmacology vol. 20,1 (2017): 94. doi: https://doi.org/10.1093/ijnp/pyw104
Erratum. Int J Neuropsychopharmacol. 2017 Jan 01;20(1):94. doi: 10.1093/ijnp/pyw104. PMID: 28927198; PMCID: PMC5578803.
Copy Download .nbib Format: NLM
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications.

The international journal of neuropsychopharmacology

Heckman PRA, van Duinen MA, Bollen EPP, Nishi A, Wennogle LP, Blokland A, Prickaerts J.
PMID: 27037577
Int J Neuropsychopharmacol. 2016 Apr 02;19(10). doi: 10.1093/ijnp/pyw030.

BACKGROUND: The fronto-striatal circuits are the common neurobiological basis for neuropsychiatric disorders, including schizophrenia, Parkinson's disease, Huntington's disease, attention deficit hyperactivity disorder, obsessive-compulsive disorder, and Tourette's syndrome. Fronto-striatal circuits consist of motor circuits, associative circuits, and limbic circuits. All...

Cite
Heckman PRA, van Duinen MA, Bollen EPP, et al. Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications. Int J Neuropsychopharmacol. 2016;19(10)doi: 10.1093/ijnp/pyw030.
Heckman, P. R. A., van Duinen, M. A., Bollen, E. P. P., Nishi, A., Wennogle, L. P., Blokland, A., & Prickaerts, J. (2016). Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications. The international journal of neuropsychopharmacology, 19(10), . https://doi.org/10.1093/ijnp/pyw030
Heckman, Pim R A, et al. "Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications." The international journal of neuropsychopharmacology vol. 19,10 (2016). doi: https://doi.org/10.1093/ijnp/pyw030
Heckman PRA, van Duinen MA, Bollen EPP, Nishi A, Wennogle LP, Blokland A, Prickaerts J. Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications. Int J Neuropsychopharmacol. 2016 Apr 02;19(10). doi: 10.1093/ijnp/pyw030. PMID: 27037577; PMCID: PMC5091819.
Copy Download .nbib Format: NLM
The role of cognitive dysfunction in the symptoms and remission from depression.

Annals of general psychiatry

Gonda X, Pompili M, Serafini G, Carvalho AF, Rihmer Z, Dome P.
PMID: 26396586
Ann Gen Psychiatry. 2015 Sep 22;14:27. doi: 10.1186/s12991-015-0068-9. eCollection 2015.

The disability and burden associated with major depression comes only in part from its affective symptoms; cognitive dysfunctions associated with depression also play a crucial role. Furthermore, these cognitive impairments during depression are manifold and multilevel affecting elementary and...

Cite
Gonda X, Pompili M, Serafini G, et al. The role of cognitive dysfunction in the symptoms and remission from depression. Ann Gen Psychiatry. 2015;14:27doi: 10.1186/s12991-015-0068-9.
Gonda, X., Pompili, M., Serafini, G., Carvalho, A. F., Rihmer, Z., & Dome, P. (2015). The role of cognitive dysfunction in the symptoms and remission from depression. Annals of general psychiatry, 1427. https://doi.org/10.1186/s12991-015-0068-9
Gonda, Xenia, et al. "The role of cognitive dysfunction in the symptoms and remission from depression." Annals of general psychiatry vol. 14 (2015): 27. doi: https://doi.org/10.1186/s12991-015-0068-9
Gonda X, Pompili M, Serafini G, Carvalho AF, Rihmer Z, Dome P. The role of cognitive dysfunction in the symptoms and remission from depression. Ann Gen Psychiatry. 2015 Sep 22;14:27. doi: 10.1186/s12991-015-0068-9. eCollection 2015. PMID: 26396586; PMCID: PMC4578787.
Copy Download .nbib Format: NLM
[No title available]

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Agrawal R, Kalmady SV, Venkatasubramanian G.
PMID: 28449558
Clin Psychopharmacol Neurosci. 2017 May 31;15(2):115-125. doi: 10.9758/cpn.2017.15.2.115.

OBJECTIVE: Deficient brain-derived neurotrophic factor (BDNF) is one of the important mechanisms underlying the neuroplasticity abnormalities in schizophrenia. Aberration in BDNF signaling pathways directly or circuitously influences neurotransmitters like glutamate and gamma-aminobutyric acid (GABA). For the first time, this...

Cite
Agrawal R, Kalmady SV, Venkatasubramanian G. . Clin Psychopharmacol Neurosci. 2017;15(2):115-125doi: 10.9758/cpn.2017.15.2.115.
Agrawal, R., Kalmady, S. V., & Venkatasubramanian, G. (2017). . Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 15(2), 115-125. https://doi.org/10.9758/cpn.2017.15.2.115
Agrawal, Rimjhim, et al. "." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 15,2 (2017): 115-125. doi: https://doi.org/10.9758/cpn.2017.15.2.115
Agrawal R, Kalmady SV, Venkatasubramanian G. . Clin Psychopharmacol Neurosci. 2017 May 31;15(2):115-125. doi: 10.9758/cpn.2017.15.2.115. PMID: 28449558; PMCID: PMC5426484.
Copy Download .nbib Format: NLM
Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Camkurt MA, Gülpamuk G, Fındiklı E, Elve R.
PMID: 28449567
Clin Psychopharmacol Neurosci. 2017 May 31;15(2):181-183. doi: 10.9758/cpn.2017.15.2.181.

Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the...

Cite
Camkurt MA, Gülpamuk G, Fındiklı E, et al. Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine. Clin Psychopharmacol Neurosci. 2017;15(2):181-183doi: 10.9758/cpn.2017.15.2.181.
Camkurt, M. A., Gülpamuk, G., Fındiklı, E., & Elve, R. (2017). Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 15(2), 181-183. https://doi.org/10.9758/cpn.2017.15.2.181
Camkurt, Mehmet Akif, et al. "Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 15,2 (2017): 181-183. doi: https://doi.org/10.9758/cpn.2017.15.2.181
Camkurt MA, Gülpamuk G, Fındiklı E, Elve R. Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine. Clin Psychopharmacol Neurosci. 2017 May 31;15(2):181-183. doi: 10.9758/cpn.2017.15.2.181. PMID: 28449567; PMCID: PMC5426493.
Copy Download .nbib Format: NLM
Low-dose Clozapine-induced Seizure: A Case Report.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Bolu A, Akarsu S, Pan E, Aydemir E, Oznur T.
PMID: 28449570
Clin Psychopharmacol Neurosci. 2017 May 31;15(2):190-193. doi: 10.9758/cpn.2017.15.2.190.

Seizures are believed to be a dose-dependent side effect of clozapine. In this case report, we describe a patient who had tonic-clonic seizures after using a low dose clozapine who did not have any seizure risk. The 29-year-old male...

Cite
Bolu A, Akarsu S, Pan E, et al. Low-dose Clozapine-induced Seizure: A Case Report. Clin Psychopharmacol Neurosci. 2017;15(2):190-193doi: 10.9758/cpn.2017.15.2.190.
Bolu, A., Akarsu, S., Pan, E., Aydemir, E., & Oznur, T. (2017). Low-dose Clozapine-induced Seizure: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 15(2), 190-193. https://doi.org/10.9758/cpn.2017.15.2.190
Bolu, Abdullah, et al. "Low-dose Clozapine-induced Seizure: A Case Report." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 15,2 (2017): 190-193. doi: https://doi.org/10.9758/cpn.2017.15.2.190
Bolu A, Akarsu S, Pan E, Aydemir E, Oznur T. Low-dose Clozapine-induced Seizure: A Case Report. Clin Psychopharmacol Neurosci. 2017 May 31;15(2):190-193. doi: 10.9758/cpn.2017.15.2.190. PMID: 28449570; PMCID: PMC5426497.
Copy Download .nbib Format: NLM
Quantitative Electroencephalography Reflects Inattention, Visual Error Responses, and Reaction Times in Male Patients with Attention Deficit Hyperactivity Disorder.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Roh SC, Park EJ, Park YC, Yoon SK, Kang JG, Kim DW, Lee SH.
PMID: 26243846
Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):180-7. doi: 10.9758/cpn.2015.13.2.180.

OBJECTIVE: Quantitative electroencephalography (qEEG) has been increasingly used to evaluate patients with attention deficit hyperactivity disorder (ADHD). The aim of this study was to assess the correlation between qEEG data and symptom severity in patients with ADHD.METHODS: Fifteen patients...

Cite
Roh SC, Park EJ, Park YC, et al. Quantitative Electroencephalography Reflects Inattention, Visual Error Responses, and Reaction Times in Male Patients with Attention Deficit Hyperactivity Disorder. Clin Psychopharmacol Neurosci. 2015;13(2):180-7doi: 10.9758/cpn.2015.13.2.180.
Roh, S. C., Park, E. J., Park, Y. C., Yoon, S. K., Kang, J. G., Kim, D. W., & Lee, S. H. (2015). Quantitative Electroencephalography Reflects Inattention, Visual Error Responses, and Reaction Times in Male Patients with Attention Deficit Hyperactivity Disorder. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 13(2), 180-7. https://doi.org/10.9758/cpn.2015.13.2.180
Roh, Sang-Choong, et al. "Quantitative Electroencephalography Reflects Inattention, Visual Error Responses, and Reaction Times in Male Patients with Attention Deficit Hyperactivity Disorder." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 13,2 (2015): 180-7. doi: https://doi.org/10.9758/cpn.2015.13.2.180
Roh SC, Park EJ, Park YC, Yoon SK, Kang JG, Kim DW, Lee SH. Quantitative Electroencephalography Reflects Inattention, Visual Error Responses, and Reaction Times in Male Patients with Attention Deficit Hyperactivity Disorder. Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):180-7. doi: 10.9758/cpn.2015.13.2.180. PMID: 26243846; PMCID: PMC4540038.
Copy Download .nbib Format: NLM
Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Wang SM, Lee HK, Kweon YS, Lee CT, Lee KU.
PMID: 26243851
Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):212-4. doi: 10.9758/cpn.2015.13.2.212.

Overactive bladder (OAB) is defined as urgency, usually with frequency and nocturia, and with or without urge incontinence. Duloxetine, an antidepressant that inhibits reuptake of serotonin and norepinephrine, is indicated for the treatment of stress urinary incontinence in Europe....

Cite
Wang SM, Lee HK, Kweon YS, et al. Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent. Clin Psychopharmacol Neurosci. 2015;13(2):212-4doi: 10.9758/cpn.2015.13.2.212.
Wang, S. M., Lee, H. K., Kweon, Y. S., Lee, C. T., & Lee, K. U. (2015). Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 13(2), 212-4. https://doi.org/10.9758/cpn.2015.13.2.212
Wang, Sheng-Min, et al. "Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 13,2 (2015): 212-4. doi: https://doi.org/10.9758/cpn.2015.13.2.212
Wang SM, Lee HK, Kweon YS, Lee CT, Lee KU. Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent. Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):212-4. doi: 10.9758/cpn.2015.13.2.212. PMID: 26243851; PMCID: PMC4540032.
Copy Download .nbib Format: NLM
Multimodal Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated with the Use of Zolpidem.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Ram D, Eiman N, Gowdappa B.
PMID: 26243852
Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):215-7. doi: 10.9758/cpn.2015.13.2.215.

We are reporting a case of zolpidem induced multimodal hallucinations in a 22 year old female without any history of psychiatric disorders. Zolpidem, by acting on gamma-amino butyric acid type A receptor has a potential to cause a paradoxical...

Cite
Ram D, Eiman N, Gowdappa B. Multimodal Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated with the Use of Zolpidem. Clin Psychopharmacol Neurosci. 2015;13(2):215-7doi: 10.9758/cpn.2015.13.2.215.
Ram, D., Eiman, N., & Gowdappa, B. (2015). Multimodal Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated with the Use of Zolpidem. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 13(2), 215-7. https://doi.org/10.9758/cpn.2015.13.2.215
Ram, Dushad, et al. "Multimodal Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated with the Use of Zolpidem." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 13,2 (2015): 215-7. doi: https://doi.org/10.9758/cpn.2015.13.2.215
Ram D, Eiman N, Gowdappa B. Multimodal Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated with the Use of Zolpidem. Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):215-7. doi: 10.9758/cpn.2015.13.2.215. PMID: 26243852; PMCID: PMC4540046.
Copy Download .nbib Format: NLM
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Sanacora G, Schatzberg AF.
PMID: 25767082
Neuropsychopharmacology. 2015 Mar 13;40(5):1307. doi: 10.1038/npp.2014.338.

No abstract available.

Cite
Sanacora G, Schatzberg AF. Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?. Neuropsychopharmacology. 2015;40(5):1307doi: 10.1038/npp.2014.338.
Sanacora, G., & Schatzberg, A. F. (2015). Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(5), 1307. https://doi.org/10.1038/npp.2014.338
Sanacora, Gerard, and Schatzberg, Alan F. "Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 40,5 (2015): 1307. doi: https://doi.org/10.1038/npp.2014.338
Sanacora G, Schatzberg AF. Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?. Neuropsychopharmacology. 2015 Mar 13;40(5):1307. doi: 10.1038/npp.2014.338. PMID: 25767082; PMCID: PMC4367478.
Copy Download .nbib Format: NLM
A brief method for preparation of gintonin-enriched fraction from ginseng.

Journal of ginseng research

Choi SH, Jung SW, Kim HS, Kim HJ, Lee BH, Kim JY, Kim JH, Hwang SH, Rhim H, Kim HC, Nah SY.
PMID: 26869834
J Ginseng Res. 2015 Oct;39(4):398-405. doi: 10.1016/j.jgr.2015.05.002. Epub 2015 Jun 09.

BACKGROUND: Ginseng has been used as a tonic for invigoration of the human body. In a previous report, we identified a novel candidate responsible for the tonic role of ginseng, designated gintonin. Gintonin induces [Ca(2+)]i transient in animal cells...

Cite
Choi SH, Jung SW, Kim HS, et al. A brief method for preparation of gintonin-enriched fraction from ginseng. J Ginseng Res. 2015;39(4):398-405doi: 10.1016/j.jgr.2015.05.002.
Choi, S. H., Jung, S. W., Kim, H. S., Kim, H. J., Lee, B. H., Kim, J. Y., Kim, J. H., Hwang, S. H., Rhim, H., Kim, H. C., & Nah, S. Y. (2015). A brief method for preparation of gintonin-enriched fraction from ginseng. Journal of ginseng research, 39(4), 398-405. https://doi.org/10.1016/j.jgr.2015.05.002
Choi, Sun-Hye, et al. "A brief method for preparation of gintonin-enriched fraction from ginseng." Journal of ginseng research vol. 39,4 (2015): 398-405. doi: https://doi.org/10.1016/j.jgr.2015.05.002
Choi SH, Jung SW, Kim HS, Kim HJ, Lee BH, Kim JY, Kim JH, Hwang SH, Rhim H, Kim HC, Nah SY. A brief method for preparation of gintonin-enriched fraction from ginseng. J Ginseng Res. 2015 Oct;39(4):398-405. doi: 10.1016/j.jgr.2015.05.002. Epub 2015 Jun 09. PMID: 26869834; PMCID: PMC4593782.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2451 entries